Cart
sales@molnova.com
Oncrasin 1
CAS No. 75629-57-1
Oncrasin 1( —— )
Catalog No. M21162 CAS No. 75629-57-1
Oncrasin 1 is a potent inhibitor of anticancer that kills various human lung cancer cells with K-Ras mutations at low or submicromolar concentrations.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 62 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 37 | In Stock |
|
| 25MG | 56 | In Stock |
|
| 50MG | 102 | In Stock |
|
| 100MG | 189 | In Stock |
|
| 200MG | 272 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOncrasin 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionOncrasin 1 is a potent inhibitor of anticancer that kills various human lung cancer cells with K-Ras mutations at low or submicromolar concentrations.
-
DescriptionOncrasin 1 is a potent inhibitor of anticancer that kills various human lung cancer cells with K-Ras mutations at low or submicromolar concentrations.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetRas
-
RecptorK-Ras
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number75629-57-1
-
Formula Weight269.73
-
Molecular FormulaC16H12ClNO
-
Purity>98% (HPLC)
-
SolubilityDMSO:43 mg/mL (159.42 mM)
-
SMILESO=Cc1cn(Cc2ccc(Cl)cc2)c2ccccc12
-
Chemical Name1-(4-Chlorobenzyl)-1H-indole-3-carbaldehyde
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Guo W Wu S Liu J et al. Identification of a Small Molecule with Synthetic Lethality for K-Ras and Protein Kinase C Iota[J]. Cancer Research 2008 68(18):7403-7408.
molnova catalog
related products
-
K-Ras G12C-IN-12
An allosteric inhibitor of oncogenic K-Ras(G12C) with EC50 of 0.32 uM in H1792 cells.
-
ARS-1630
ARS-1630 is the R-conformational atropisomer of ARS-1620.
-
MRTX1133
MRTX1133 is a potent, selective, noncovalent KRASG12D inhibitor. It has picomolar binding affinity, single-digit nanomolar activity in cellular assays. In addition, it has significant in vivo efficacy in tumor models harboring KRASG12D mutations.
